Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

Similar articles for PubMed (Select 22295954)

1.

β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.

Song X, Song SK, Zhao P, Wei LM, Jiao HS.

Pharm Dev Technol. 2013 Sep-Oct;18(5):1220-9. doi: 10.3109/10837450.2011.635152. Epub 2012 Feb 1.

PMID:
22295954
2.
3.
4.
5.

The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.

Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.

Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003. Epub 2009 Aug 12.

PMID:
19717287
6.

Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.

Yang Y, Gao Y, Mei X.

Pharm Dev Technol. 2013 Sep-Oct;18(5):1169-74. doi: 10.3109/10837450.2011.618948. Epub 2011 Oct 4.

PMID:
21967467
7.
8.

Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.

Chaisri W, Ghassemi AH, Hennink WE, Okonogi S.

Colloids Surf B Biointerfaces. 2011 Jun 1;84(2):508-14. doi: 10.1016/j.colsurfb.2011.02.006. Epub 2011 Feb 25.

PMID:
21353499
9.
10.

Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.

Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T.

Int J Pharm. 2007 Apr 4;334(1-2):137-48. Epub 2006 Oct 28.

PMID:
17196348
12.

Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.

He JT, Su HB, Li GP, Tao XM, Mo W, Song HY.

Int J Pharm. 2006 Feb 17;309(1-2):101-8. Epub 2006 Jan 4.

PMID:
16413979
13.

Formulation optimization of serratiopeptidase-loaded PLGA microspheres using selected variables.

Singh D, Dixit VK, Saraf S, Saraf S.

PDA J Pharm Sci Technol. 2009 Mar-Apr;63(2):103-12.

PMID:
19634349
14.

Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting.

Diab R, Brillault J, Bardy A, Gontijo AV, Olivier JC.

Int J Pharm. 2012 Oct 15;436(1-2):833-9. doi: 10.1016/j.ijpharm.2012.07.036. Epub 2012 Jul 28.

PMID:
22846409
15.

Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.

Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.

Pharm Dev Technol. 2011 Aug;16(4):377-84. doi: 10.3109/10837451003739297. Epub 2010 Apr 7.

PMID:
20370594
16.

Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.

Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y.

Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1251-6.

17.
18.
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk